These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2499289)

  • 21. 17β-Oestradiol indirectly inhibits thyrotrophin-releasing hormone expression in the hypothalamic paraventricular nucleus of female rats and blunts thyroid axis response to cold exposure.
    Uribe RM; Zacarias M; Corkidi G; Cisneros M; Charli JL; Joseph-Bravo P
    J Neuroendocrinol; 2009 May; 21(5):439-48. PubMed ID: 19302192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of biogenic amines and TRH on release of prolactin and TSH in the rat.
    Chen HJ; Meites J
    Endocrinology; 1975 Jan; 96(1):10-4. PubMed ID: 803259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotropin-releasing hormone receptor activation in the spinal cord increases blood pressure and sympathetic tone to the vasculature and the adrenals.
    Helke CJ; Phillips ET
    J Pharmacol Exp Ther; 1988 Apr; 245(1):41-6. PubMed ID: 2834544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potency of the N3im-methyl analog of TRH in the induction of shaking movements in the rat.
    Wei E; Loh H; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):227-9. PubMed ID: 816658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of CNS-active drugs on TRH-induced prolactin release.
    Hylka VW; Forman LJ; Sonntag WE; Meites J
    Life Sci; 1986 Jan; 38(1):51-7. PubMed ID: 2934599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of oestriol and tamoxifen on oestradiol induced prolactin secretion in anaesthetised rats.
    Gilna P; Martin F
    Acta Endocrinol (Copenh); 1986 May; 112(1):71-8. PubMed ID: 3087134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactivity of plasma prolactin in ovariectomized, diethylstilbestrol-treated Long-Evans and Holtzman rats after thyrotropin-releasing hormone or bromocriptine administration.
    Cannon M; Hu L; Ye J; Lawson D
    Proc Soc Exp Biol Med; 1991 Sep; 197(4):465-70. PubMed ID: 1908099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation of the cardiovascular and prolactin-releasing activities of norvaline2-TRH.
    Labroo VM; Cohen LA; Lozovsky D; Siren AL; Feuerstein G
    Neuropeptides; 1987 Jul; 10(1):29-36. PubMed ID: 3118236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    Breese GR; Coyle S; Towle AC; Mueller RA; McCown TJ; Frye GD
    J Pharmacol Exp Ther; 1984 Jun; 229(3):731-7. PubMed ID: 6427448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic intra-accumbens administration of the TRH analogue CG3509 on histamine-induced behaviour in the rat.
    Bristow LJ; Bennett GW
    Br J Pharmacol; 1989 Jul; 97(3):745-52. PubMed ID: 2503226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrotropin-releasing hormone and its analog MK-771 increase the cerebroventricular perfusate content of dihydroxyphenylacetic acid.
    Nielsen JA; Moore KE
    J Neurochem; 1984 Aug; 43(2):593-6. PubMed ID: 6429282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in the prolactin response to thyrotropin-releasing hormone (TRH) during the menstrual cycle of normal women.
    Boyd AE; Sanchez-Franco F
    J Clin Endocrinol Metab; 1977 May; 44(5):985-9. PubMed ID: 404311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the effect of the thyrotropin-releasing hormone metabolite, histidyl-proline diketopiperazine, on prolactin secretion in vivo.
    Emerson CH; Alex S; Braverman LE; Safran MS
    Endocrinology; 1981 Nov; 109(5):1375-9. PubMed ID: 7197618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH).
    Webster VA; Griffiths EC; Slater P
    Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative maturation of the regulation of prolactin and thyrotropin by serotonin and thyrotropin-releasing hormone in male and female rats.
    Becú D; Libertun C
    Endocrinology; 1982 Jun; 110(6):1879-84. PubMed ID: 6804214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ability of RX 77368 - a stabilised analogue of TRH - to provoke the secretion of prolactin and TSH in vivo.
    Dettmar PW; Lynn AG; Metcalf G; Clifford JM
    Neuropeptides; 1982 Oct; 3(1):1-8. PubMed ID: 6818488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin-releasing factor (PRF) in porcine hypothalamic extract distinct from TRH.
    Boyd AE; Spencer E; Jackson IM; Reichlin S
    Endocrinology; 1976 Sep; 99(3):861-71. PubMed ID: 821745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.